New Zealand markets open in 2 hours 14 minutes

Haemonetics Corporation (HAE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
92.03+0.53 (+0.58%)
As of 03:46PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.65B
Enterprise value 5.32B
Trailing P/E 37.20
Forward P/E 21.28
PEG ratio (5-yr expected) 1.77
Price/sales (ttm)3.70
Price/book (mrq)4.93
Enterprise value/revenue 4.19
Enterprise value/EBITDA 20.19

Trading information

Stock price history

Beta (5Y monthly) 0.36
52-week change 312.05%
S&P500 52-week change 324.19%
52-week high 395.26
52-week low 370.74
50-day moving average 380.52
200-day moving average 384.89

Share statistics

Avg vol (3-month) 3496.42k
Avg vol (10-day) 3498.45k
Shares outstanding 550.79M
Implied shares outstanding 650.79M
Float 850.37M
% held by insiders 10.76%
% held by institutions 1101.57%
Shares short (15 Apr 2024) 42.24M
Short ratio (15 Apr 2024) 45.08
Short % of float (15 Apr 2024) 46.71%
Short % of shares outstanding (15 Apr 2024) 44.41%
Shares short (prior month 15 Mar 2024) 42.18M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 303 Dec 2012

Financial highlights

Fiscal year

Fiscal year ends 01 Apr 2023
Most-recent quarter (mrq)30 Dec 2023

Profitability

Profit margin 9.97%
Operating margin (ttm)16.04%

Management effectiveness

Return on assets (ttm)6.12%
Return on equity (ttm)14.72%

Income statement

Revenue (ttm)1.27B
Revenue per share (ttm)25.09
Quarterly revenue growth (yoy)10.10%
Gross profit (ttm)N/A
EBITDA 293.09M
Net income avi to common (ttm)126.57M
Diluted EPS (ttm)2.46
Quarterly earnings growth (yoy)-5.20%

Balance sheet

Total cash (mrq)195.12M
Total cash per share (mrq)3.84
Total debt (mrq)871.06M
Total debt/equity (mrq)92.34%
Current ratio (mrq)2.92
Book value per share (mrq)18.58

Cash flow statement

Operating cash flow (ttm)197.28M
Levered free cash flow (ttm)117.23M